Related Experiment Video
Updated: Jan 22, 2026

Author Spotlight: Modeling Brain Tumors In Vivo Using Electroporation-Based Delivery of Plasmid DNA Representing Patient Mutation Signatures
Published on: June 23, 2023
Prediction Model for Audiological Outcomes in Patients With GJB2 Mutations
Pey-Yu Chen1,2,3, Yin-Hung Lin1,4, Tien-Chen Liu1
1Department of Otolaryngology, National Taiwan University Hospital, Taipei, Taiwan.
Baseline hearing level and follow-up duration predict hearing outcomes in GJB2-related sensorineural hearing impairment (SNHI). This study establishes a predictive model for SNHI, aiding clinical management.
Area of Science:
- Genetics
- Audiology
- Otolaryngology
Background:
- Recessive GJB2 mutations are the leading genetic cause of sensorineural hearing impairment (SNHI).
- SNHI associated with GJB2 mutations exhibits significant variability in audiological features.
- A reliable predictive model for hearing outcomes in GJB2-related SNHI has been lacking.
Purpose of the Study:
- To identify key factors influencing hearing outcomes in patients with GJB2 mutations.
- To develop a predictive model for SNHI in individuals with GJB2 mutations.
Main Methods:
- Analysis of audiological data from 434 patients with biallelic GJB2 mutations, categorized by genotype.
- Comparison of hearing levels and audiogram configurations across different genotype groups.
- Application of univariate and multivariate generalized estimating equation (GEE) analyses to longitudinal audiological records.
Main Results:
- Significant differences in hearing levels and audiogram configurations were observed among the three genotype groups.
- Multivariate GEE analysis identified baseline hearing level and duration of follow-up as primary predictors of hearing outcome.
- A predictive formula was established: Predicted Hearing Level (dBHL) = 3.78 + 0.96 × (Baseline Hearing Level [dBHL]) + 0.55 × (Duration of Follow-Up [y]).
Conclusions:
- Baseline hearing level and follow-up duration are crucial prognostic factors for GJB2-related SNHI.
- The developed predictive model offers valuable insights for clinical management.
- Findings support informed follow-up protocols and treatment strategies for patients with GJB2 mutations.
More Related Videos
13:34A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
Published on: April 6, 2016
07:42Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
Published on: February 7, 2021
Related Concept Videos
Predicting Reaction Outcomes
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Viral Mutations
Predicting Molecular Geometry
Mutation, Gene Flow, and Genetic Drift